19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace





powered by centersite dot net
Basic InformationLatest News
FDA Adds Abuse Warning to Labels for Xanax, ValiumStatins Going Generic Saved Medicare BillionsMany Cases of 'Penicillin Allergy' Might Be MistakenCOVID Drug Remdesivir Could Cost Up to $3,120 Per Patient, Maker SaysHigh Costs Lead Millions of Americans to Shop Abroad for Rx DrugsFDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19How Ritalin Works in the BrainFDA Pulls Heartburn Drug Zantac From MarketTaking More Antibiotics May Up Odds for HospitalizationAllergy Med Singulair to Get 'Black Box' Warning Over Psych Side Effects: FDAU.S. Drug Prices Have Risen Three Times Faster Than InflationUse Pot? It Can Interact With Your Meds in Harmful WaysToo Many Antibiotics, Opioids Given to Dental Patients in the ERBrand-Name Rx Rise After Docs Get Drug Company Perks: StudyAs Prices Rise for Parkinson's, Alzheimer's Meds, Patients Go WithoutPrice Hikes Have Patients Turning to Craigslist for Insulin, Asthma InhalersAI May Help Guide Patients to Most Effective Antidepressant1 in 4 Gets Unneeded Antibiotics at Children's HospitalsStudy Finds 'No Clear Rationale' for 45% of Antibiotic PrescriptionsAre Antibiotics a Recipe for Obesity in Childhood?Do You Take Warfarin? Time of Day Might Not MatterNew Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?Health Tip: Acetaminophen SafetyTwo More Heartburn Meds Recalled Due to Possible CarcinogenMany Drugstores Misinform on Disposal of Unused MedsHealth Tip: How to Remember to Take Your MedicationsFDA to Allow States to Import Prescription Drugs From Other CountriesOver 40% of Antibiotics Could Be 'Inappropriately' PrescribedFDA Testing Levels of Carcinogen in Diabetes Drug MetforminTaking Several Prescription Drugs May Trigger Serious Side EffectsPenicillin Allergy Less Common Than Thought: StudyMany Older Americans Misuse Antibiotics: PollAntibiotics Not Recommended for Most Toothaches, New Guideline SaysHealth Tip: Taking Anti-Inflammatory DrugsMany Common Meds Could Alter Your MicrobiomeWhen Meds Are Free, Patients Take Them More OftenHealth Tip: Packing Prescriptions for Travel
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

As Prices Rise for Parkinson's, Alzheimer's Meds, Patients Go Without

HealthDay News
by By Dennis ThompsonHealthDay Reporter
Updated: Feb 19th 2020

new article illustration

WEDNESDAY, Feb. 19, 2020 (HealthDay News) -- Rising drug costs are hampering the care of patients with debilitating neurological disorders like Parkinson's disease and Alzheimer's, a new study finds.

Patients are less likely to fill necessary prescriptions as out-of-pocket costs increase, said senior researcher Dr. Brian Callaghan, a neurologist with the University of Michigan, in Ann Arbor.

"It's a pretty predictable 5% to 10% drop for every $50 increase in cost," Callaghan said.

For patients with Parkinson's disease, not taking medications as prescribed can severely impact their quality of life, he noted.

"The Parkinson's medicines are supposed to help make their tremors better, help them walk faster better. Theoretically, it could prevent falls and hospitalizations," Callaghan said. "It's not really preventing people from dying. It's enabling people to live better and have better symptom control."

Previous studies have shown that out-of-pocket drug costs are rising for neurologic medications, Callaghan said.

To see how these higher prices affect patient care, Callaghan and his colleagues singled out three neurologic diseases for which there are effective drugs available at a wide variety of prices:

  • Parkinson's disease, where the drug pramipexole cost $35.90 for a 30-day supply in 2016, compared to $12.40 for the drug ropinirole.
  • Alzheimer's disease, where a month's supply of rivastigmine was $79.30, compared to $3.10 for the drug donepezil.
  • Peripheral neuropathy, where pregabalin cost $65.70 for a month compared to $8.40 for gabapentin.

The researchers used a private insurance claims database to track more than 80,000 patients' prescriptions during a 15-year period, comparing how often they filled prescriptions with their out-of-pocket costs.

In 2015, the Alzheimer's drug donepezil cost about $3 for a 30-day supply, and researchers found that people filled their prescriptions about 70% of the time. On the other hand, the drug rivastigmine cost about $100, and people filled those prescriptions only 45% of the time.

A $50 increase in out-of-pocket costs was associated with an overall 12% decrease in a patient's access to Alzheimer's medications, the researchers found.

The same pattern held for Parkinson's patients and people with peripheral neuropathy, which causes numbness and pain, usually in the hands and feet.

"I am not surprised," James Beck, chief scientific officer for the Parkinson's Foundation, said of the study results. "The free Parkinson's Foundation Helpline team hears similar stories from people with Parkinson's disease every day. The cost of medications is a key factor in their budgets and everyday lives."

The medication regimen for people with Parkinson's is especially complex, "and the timing of multiple pills a day often taking into account meals is incredibly arduous," Beck said. "Therefore, missing doses of medications will have the effect of a reduction in quality of life. People may not be able to move as well, sleep as well, or do the activities they enjoy as a result of missing their medications."

Callaghan pointed out that medication adherence is probably even worse for patients with disorders like multiple sclerosis, where there are only a handful of medicines available and all are expensive.

Callaghan and Beck recommended that patients talk with their doctor and pharmacist if they're struggling to pay for their medications. There could be cheaper drugs available that would work as effectively.

"For Parkinson's disease, there are three types of medications that people often take as their first medication. The evidence suggests that starting with any of these medications leads to similar positive outcomes," Beck said. "Therefore, people with Parkinson's disease and their providers can work together to identify what might be the most affordable medication to start with in treating their Parkinson's disease symptoms."

The study was published online Feb. 19 in the journal Neurology.

More information

The National Parkinson's Foundation has more about living with Parkinson's.